Clinical Trial Update: Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral vancomycin for primary prophylaxis of Clostridioides difficile infection in patients on high-risk antibiotics; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: St. Luke's Hospital, Chesterfield, Missouri | Conditions: Clostridium Difficile Infection, Prophylaxis | Phase 4 | Status: COMPLETED | Results posted: 2017-12-27